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patient requires vasodilatation as well as inotropic sup- 
port. 
2. If an arterial graft is suspected to be in spasm or the 
patient has symptoms of hypoperfusion syndrome, possi- 
bly caused by graft constriction (manifested by low cardiac 
output, left ventricular failure, rising pulmonary wedge 
pressure, and hypotensionl), milrinone may be given as a 
vasodilator in combination with other therapies in an 
attempt to dilate the possibly constricted graft or coronary 
artery. It is particularly indicated when other traditional 
vasodilators uch as nitroglycerin have been used and 
found to be of little help: In this situation, milrinone is 
probably well indicated because tolerance to nitroglycerin 
is suspected. 
3. When milrinone is used in combination with nitro- 
glycerin, these two vasodilators may have a synergistic 
vasorelaxant effect. Reduced doses of the vasodilators 
may be sufficient to obtain the desirable vasorelaxant 
effect either in bypass grafts or in the systemic (or 
coronary) circulation. 
Guo-Wei He, MD, PhD 
Professor of Cardiothoracic Surgery 
The University of Hong Kong 
Grantham Hospital 
125 Wong Chuk Hang Road 
Aberdeen, Hong Kong 
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Hyperoxic cardiopuimonary bypass causes 
reoxygenation injury and lipid peroxidation 
To the Editor: 
With great interest I read the brief communication 
"Contribution of Hyperoxia to Lipid Peroxidation in 
Coronary Artery Operations: Should We Keep a Low 
Oxygen Tension?" by Hadjinikolaou and colleagues (J 
Thorac Cardiovasc Surg 1997;113:212-3). However, I have 
to disagree with several of their statements. 
First, the comment hat "the contribution of hyper- 
oxia to oxygen free radical generation and consequent 
lipid peroxidation in cardiac operations has to date not 
been addressed" is wrong. We intensively studied the 
effect of hyperoxic ardiopulmonary bypass (CPB) on 
oxygen-derived free radical-induced lipid peroxidation in 











Fig. 1. Malondialdehyde (MDA) as a measure of lipid 
peroxidation from systemic venous blood at the start and 
end of CPB. The hyperoxic group included 10 patients 
during coronary artery bypass graft operations in which 
CPB was conducted in a hyperoxic fashion (Po 2 = 450 mm 
Hg). The normoxic group consisted of 10 patients also 
undergoing coronary artery bypass graft operations in 
which CPB was run with reduced oxygen levels (Po 2 150 
mm Hg). The groups did not differ in terms of age, sex, 
severity of disease, contractility, number of grafts, length 
of CPB, or ischemic time. *p < 0.05 versus hyperoxic 
group (analysis of variance). 
The results show that hyperoxic CPB causes reoxygen- 
ation damage, leading to lipid peroxidation, reduced 
antioxidant reserve capacity, creatine kinase release, 
and impaired postbypass contractility in hypoxic imma- 
ture hearts. I-e' 6 Reports by other groups also address 
the issue] Additionally, in normoxic adult hearts, hy- 
peroxic CPB causes lipid peroxidation, creatine kinase 
and lactate dehydrogenase r lease, and an increase in 
polymorphonuclear leukocyte lastase. 5 
Second, the authors further state that lipid peroxida- 
tion is absent during CPB. Additionally, they did not 
find a relationship between the degree of hyperoxia nd 
levels of lipid peroxidation. The results of our studies 
clearly indicate the existence of lipid peroxidation as 
early as 5 minutes after the start of CPB. We measured 
conjugated ienes as a marker of lipid peroxidation. 
Compared with results in control subjects without hy- 
poxia, hyperoxic CPB (oxygen tension [Po2] = 400 mm 
Hg) caused a 13-fold increase in myocardial conjugated 
diene production during cardioplegic induction (5 min- 
utes after the start of CPB) in hypoxic immature 
hearts.Z, 3 Reduction of Po2 during CPB to normoxic 
levels (100 mm Hg) resulted in significantly (73%) 
2 3 lower production of myocardial conjugated ienes. " 
Furthermore, for the first time, we described a new 
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method of "controlled reoxygenation," in which CPB is 
started with ambient Po2 (30 mm Hg) and normoxic 
reoxygenation is begun at the time of cardioplegic 
arrest. 4 Applying this method, we were able to avoid 
biochemical evidence of reoxygenation i jury and to 
present almost complete functional recovery in previ- 
ously hypoxic hearts. 4 
In normoxic adult hearts we demonstrated a beneficial 
effect in terms of enzyme release, polymorphonuclear 
leukocyte lastase production, and especially lipid peroxi- 
dation, by lowering oxygen levels (150 mm Hg) in the 
extracorporeal circuit 5 (Fig. 1). 
We were also able to show that treatment with oxygen- 
derived free radical scavengers can limit reoxygenation 
injury and avoid lipid peroxidation during CPB. 6 I there- 
fore partly agree with the authors, although we found 
convincing evidence that reduced Po 2 during CPB is more 
important and is indeed absolutely vital. Hyperoxia is not 
physiologic, it is damaging to all organs, and above all it is 
absolutely not necessary. I truly believe that within 5 to 10 
years, CPB in hypoxic immature hearts, as well as in 
normoxic adult hearts, will be instituted only in a nor- 
moxic fashion to avoid oxygenation damage and lipid 
peroxidation. 
Kai Ihnken, MD 
Stanford University Hospital 
Department of Surgery 
Room H3680 
300 Pasteur Dr. 
Stanford, CA 94305 
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Reply to the Editor: 
We studied lipid peroxidation in adult patients un- 
dergoing cardiopulmonary bypass (CPB) for routine 
coronary artery bypass grafting (CABG). Assumptions 
about lipid peroxidation based on observations in im- 
mature piglets and cyanotic children with tetralogy of 
Fallot I may not be reliably transferred to adult human 
beings. During CPB, lipid peroxidation may well vary in 
different settings. Morita, 2 Ihnken, 3and their associates 
measured conjugated ienes and malondialdehyde as
markers of lipid peroxidation in the myocardium of 
immature piglets and found a significant increase 5 
minutes after the start of CPB. However, Davies and 
coworkers 4 measured lipid peroxidation i the coronary 
sinus in adult patients undergoing routine CABG and 
found no significant changes during CPB. The only 
related study seems to be an abstract reporting the 
results of a comparison between hyperoxic (Po 2 400 mm 
Hg) and normoxic (Po2 150 mm Hg) CPB in 20 adult 
patients (63 _+ 8 years) undergoing CABG. 5 Unfortu- 
nately, several questions arise from this report. Apart 
from being a very small study, the number of patients in 
each of the two groups was not stated. Crossclamp 
times and CPB times between the two groups were not 
compared, although their significance in lipid peroxida- 
tion is beyond question. Longer ischemic damage in the 
normoxic group might well have resulted in higher 
creatine kinase and malondialdehyde levels. Therefore 
our comment that "the contribution of hyperoxia to 
free radical generation and consequent lipid peroxida- 
tion in adult cardiac operations has to date not been 
addressed" should not be dismissed lightly. 
Leonidas Hadjinikolaou, MD 
Cardiothoracic Department 
St. Mary's Hospital 
Praed Street 
London W2 1NY,, United Kingdom 
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